JOHN MENDLEIN Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for JOHN MENDLEIN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of JOHN MENDLEIN. JOHN MENDLEIN is a Director in ACLARA BIOSCIENCES INC ($ACLA) and an CEO & Executive Chariman in aTYR PHARMA INC ($LIFE) and a CEO and Director in aTYR PHARMA INC ($LIFE) and an CEO and Executive Chairman in aTYR PHARMA INC ($LIFE) and a Director in aTYR PHARMA INC ($LIFE) and a See Remarks in aTYR PHARMA INC ($LIFE) and a Director in FATE THERAPEUTICS INC ($FATE) and a Director in Editas Medicine, Inc. ($EDIT).
Address: 99 HARBOUR SQUARE #2708 TORONTO CANADA M5J2H2
Companies in which JOHN MENDLEIN is an Insider
ACLARA BIOSCIENCES INC
Industry: MEASURING & CONTROLLING DEVICES, NEC [3829]
Position of JOHN MENDLEIN: Director
Holdings: 0 shares
Latest Transaction: Dec 10 2004
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
aTYR PHARMA INC
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of JOHN MENDLEIN: CEO and Director, See Remarks, CEO and Executive Chairman, CEO & Executive Chariman
Holdings: 420,382 shares
Current Value: $1,429,299
Latest Transaction: May 10 2019
$LIFE Market Capitalization: $78.27M
$LIFE Previous Close: $3.40
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Editas Medicine, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of JOHN MENDLEIN: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jun 19 2017
$EDIT Market Capitalization: $636.78M
$EDIT Previous Close: $18.56
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
FATE THERAPEUTICS INC
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of JOHN MENDLEIN: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: May 05 2020
$FATE Market Capitalization: $95.27M
$FATE Previous Close: $2.80
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of JOHN MENDLEIN
Sentiment: All, ACLA, LIFE, EDIT, FATE
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 05 2020 | FATE | FATE THERAPEUTICS ... | MENDLEIN JOHN | Director | Option Exercise | A | 26.59 | 16,000 | 425,440 | 16,000 | |
| May 10 2019 | LIFE | aTYR PHARMA INC | MENDLEIN JOHN | Director | Option Exercise | A | 0.58 | 20,000 | 11,668 | 20,000 | |
| May 07 2019 | FATE | FATE THERAPEUTICS ... | MENDLEIN JOHN | Director | Option Exercise | A | 17.15 | 16,000 | 274,400 | 16,000 | |
| Dec 26 2018 | LIFE | aTYR PHARMA INC | MENDLEIN JOHN | Director | Buy | P | 0.42 | 195,000 | 82,602 | 615,382 | 420.4 K to 615.4 K (+46.39 %) |
| Dec 26 2018 | LIFE | aTYR PHARMA INC | MENDLEIN JOHN | Director | Buy | P | 0.41 | 50,000 | 20,645 | 420,382 | 370.4 K to 420.4 K (+13.50 %) |
| May 17 2018 | LIFE | aTYR PHARMA INC | MENDLEIN JOHN | Director | Option Exercise | A | 1.35 | 20,000 | 27,000 | 20,000 | |
| May 04 2018 | FATE | FATE THERAPEUTICS ... | MENDLEIN JOHN | Director | Option Exercise | A | 9.78 | 16,000 | 156,480 | 16,000 |